Gainers
- Clearfield CLFD shares are trading higher after the company reported better-than-expected Q3 EPS and sales results.
- Scientific Games SGMS shares are trading higher after the company reported better-than-expected Q2 sales results.
- Advanced Micro Devices AMD shares are trading higher after Intel reported Q2 earnings results and traded lower.
- Adaptimmune Therapeutics ADAP shares are trading higher after the company reported it was granted access to priority medicines regulatory support by EMA for ADP-A2M4 for treatment of Synovial Sarcoma.
- Theratechnologies THTX shares are trading higher after the company reported that Tesamorelin improves liver health.
- SciPlay SCPL shares are trading higher after the company reported better-than-expected Q2 EPS and sales results.
- Mattel MAT shares are trading higher after the company reported better-than-expected Q2 EPS and sales results.
- BJ's Restaurants BJRI shares are trading higher after the company reported better-than-expected Q2 EPS results.
- Skechers USA SKX shares are trading higher after the company reported better-than-expected Q2 EPS and sales results.
- Edwards Lifesciences EW shares are trading higher after the company reported better-than-expected Q2 EPS and sales results. The company also raised FY20 EPS guidance above estimates.
- Radius Health RDUS shares are trading higher after the company, and Menarini Group, announced they entered into an exclusive global license agreement for the development and commercialization of elacestrant.
- LeMaitre Vascular LMAT shares are trading higher after the company reported better-than expected Q2 EPS and sales results. The company also issued Q3 EPS and sales guidance.
- miRagen Therapeutics MGEN shares are trading higher after the company received orphan drug designation for cobomarsen from the FDA for the treatment of T-cell lymphoma.
Losers
- Intel INTC shares are trading lower despite the company reporting better-than-expected Q2 EPS and earnings results.
- EHealth EHTH shares are trading lower after the company reported Q2 earnings results.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in